Skip to main content
. 2013 Dec 19;142(10):2159–2165. doi: 10.1017/S0950268813003221

Table 1.

Age distribution of the patients with E30-positive samples

Age group (years) Total no. of patients investigated E30-positive patients n (%) Negative patients n (%)
0–4 26 11 (42·3) 15 (57·7)
5–9 58 47 (81·0) 11 (19·0)
10–14 43 35 (81·4) 8 (18·6)
>15 30 24 (80·0) 6 (20·0)